BI And Lilly Eye Acute Heart Failure Opportunity For Jardiance
First SGLT Inhibitor To Work In These Patients
Having strongly made the case for Jardiance as a treatment for chronic heart failure, Boehringer Ingelheim and Eli Lilly believe the SGLT2 inhibitor could have a lot of potential in acute heart failure as well after promising data from the EMPULSE study.
